NC-LENOVO
9.3.2023 16:01:33 CET | Business Wire | Press release
Lenovo today announced the launch of the ThinkStation PX, P7 and P5, delivering a new trio of the most technologically advanced desktop workstations the company has ever built. Redesigned from the ground up to exceed today’s most extreme, high-computing workloads across industries, these new workstations feature the latest processor technology from Intel® ranging up to 120 cores and support for high-end NVIDIA RTX™ professional GPUs. Additionally, the new workstations boast all-new groundbreaking chassis designs and advanced thermals, as well as BMC capabilities1 for streamlined remote system monitoring. From virtual reality and mixed reality experiences and virtual production, to machine learning, data science, computer aided engineering (CAE), reality capture and AI, these next-generation workstations meet the ever-increasing demands for more power, performance, and speed in a scalable and future-proofed way for this new hybrid-work world.
“These new desktop workstations have been meticulously designed with a customer-centric lens in order to meet desired business outcomes and deliver innovative new solutions that our customers can enjoy well into the future as workloads increase in complexity,” said Rob Herman, vice president of Lenovo’s Workstation and Client AI Business Unit. “We partnered closely with Intel®, NVIDIA and Aston Martin to ensure these new systems offer the best of form and functionality by combining a premium chassis with ultra high-end graphics, memory and processing power.”
To bring this trio of workstations to life, Lenovo partnered with its customer Aston Martin, a renowned high-performance automotive manufacturer and leader in the ultra-luxury vehicle market, to co-design the new ThinkStation chassis. In line with Aston Martin’s design philosophy, the collaboration sought to reflect Lenovo’s iconic red design language, provide the highest possible performance, and enable enhanced levels of customization. Designers from Lenovo and Aston Martin worked collaboratively to craft the ultimate performance machines, allowing workstation users to amplify every single stage of their complex workflows. To do this, the teams conceived a new tool-less chassis design that allows extreme flexibility and enhanced ergonomics.
With a focus on achieving maximum performance, the chassis’ 3D grill is directly inspired by Aston Martin’s iconic DBS grand tourer, applying design insights from the high-performance automotive segment to a desktop workstation. Redesigned air baffles and larger 3D hex ventilation openings, along with Lenovo’s patented tri-channel cooling system, allow for unobstructed airflow – ensuring maximum cold air intake and hot air exhaust. As a result, the iconic chassis maximizes performance of CPUs, GPUs, memory, and storage. Additionally, all three of the new workstations boast an innovative, modular design with front access drives for easy serviceability and upgrade flexibility.
“The design collaboration of Lenovo’s new ThinkStation chassis has been an amazing three-year journey,” said Cathal Loughnane, director of Aston Martin Partnerships. “As Lenovo workstation customers ourselves this project was a unique opportunity to craft a high-performance system that we will use to design and develop our high-performance vehicles.”
Lenovo ThinkStation PX: For Ultimate Desktop to Data Center Flexibility
Lenovo’s highest-end, flagship workstation product offering, the Lenovo ThinkStation PX reaches extreme levels of power and performance with support for more cores and expandability than previous generations of Lenovo workstations. Rack-optimized, the ThinkStation PX offers the flexibility needed for both desktop and data center environments, enabling a seamless transition between the two. This versatile new workstation is powered by the latest 4th Gen Intel® Xeon® Scalable processors, which offers up to 120 CPU cores and boasts a 53% average performance gain over the prior generation2. The ThinkStation PX also offers support for up to four dual-slot NVIDIA RTX™ 6000 Ada Generation GPUs, so users can manage and execute the most complex workflows found in today’s work environments including creative finishing and CAE simulation. The new desktop workstation, with up to 2TB of DDR5 memory and ultra-fast bandwidth through PCIe Gen 5 lanes provides flexibility for multi-user virtualization in hybrid workflow environments — whether in the data center or carpet clusters under the desktop. Finally, this workstation offers an efficient 1850W PSU and optional redundant power supplies.
Lenovo ThinkStation P7: Staggering, Single-Socket Power
The ThinkStation P7 features a breakthrough new compute architecture with the latest Intel® Xeon® W processors, supporting up to 56 cores in a single socket, for reimagined power needed to tackle compute-intensive, multithreaded tasks head-on. Designed to exceed the most rigorous performance and reliability challenges of workloads that typically relied on servers or cloud resources in the past, the ThinkStation P7 is also rack-optimized for use in a variety of desktop and data center environments in a 4U enclosure. With support for up to three dual-slot NVIDIA RTX™ 6000 Ada Generation GPUs, the ThinkStation P7 is ideal for content creators, architects, designers, engineers and data scientists who require unprecedented graphics, visualization, real-time rendering, CAE and AI performance. From automotive styling and computational fluid dynamics analysis to complex video production and rendering workflows, the ThinkStation P7 can take on the toughest challenges.
“We are excited to offer the new lineup of Xeon W processors, built on a breakthrough new compute architecture and packaging with significantly more cores to accelerate performance across the fastest growing workloads that businesses depend on today,” said Roger Chandler, vice president of CCG and general manager, Creator and Workstation Solution team at Intel. “These processors are built to ensure professional innovators, including creators, engineers and data scientists, have the power and stability needed to create the industry's latest innovations.”
Lenovo ThinkStation P5: Future-Proofed for Versatility, Reliability and Performance
A workhorse of a desktop workstation, the ThinkStation P5 is engineered for a wide number of industry verticals and has been redesigned to satisfy users’ demand for higher levels of performance, IT expandability and ease of management in the enterprise. The next-generation workstation features a newly designed chassis, the latest Intel® Xeon® W processors, which offer up to 24 cores, and support for up to two NVIDIA RTX A6000 professional graphics cards. High-speed DDR5 memory and PCIe Gen 5 bandwidth deliver extreme configurability that caters to end-users’ unique needs. Optimized for architects, designers, engineers, and creatives alike, this workstation shines in solid modeling and compute-intensive tasks including BIM, complex 3D CAD, reality capture and geospatial visualization, visual effects, and edge deployments.
“NVIDIA offers the world’s most powerful visual computing GPUs for desktop workstations,” said Bob Pette, vice president of Professional Visualization at NVIDIA. “These are featured in all three of Lenovo’s new ThinkStation desktop systems, equipping data scientists, engineers and creative professionals with the high-performance technology they need to work with massive datasets, innovate faster, and elevate their AI and compute-intensive workflows of tomorrow.”
The ThinkStation PX, P7 and P5 workstations are designed to work within some of the most demanding professionally managed IT workplace environments and provide essential enterprise-grade features and security. Lenovo’s rigorous standards and testing, ThinkStation Diagnostics 2.0, ThinkShield support, upgrades to Premier Support and three-year warranty, deliver the peace of mind needed to work confidently and more securely.
The three new workstations will be available starting in May 20233. To learn more about the latest additions to Lenovo’s workstation product portfolio, visit: www.lenovo.com/thinkstations
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 82,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into key growth areas including server, storage, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere. To find out more visit www.lenovo.com, and read about the latest news via our Storyhub.
LENOVO, THINKSTATION and THINKSHIELD are trademarks of Lenovo. Intel and Xeon are trademarks of Intel Corporation or its subsidiaries in the U.S. and/or other countries. NVIDIA and RTX are trademarks of NVIDIA Corporation. Inc. All other trademarks are the property of their respective owners. ©2023, Lenovo Group Limited.
1 This add in card will not be available until later in 2023.
2 See [G1] at intel.com/processorclaims: 4th Gen Intel® Xeon® Scalable processors. Results may vary.
3 Availability may vary by geography and products may only be available in select markets.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005029/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
